查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2049626

止咳糖漿市場報告：按產品類型、年齡層、銷售管道和地區分類（2026-2034 年）

Cough Syrup Market Report by Product Type (Expectorants, Cough Suppressants/Antitussives, Combination Medications), Age Group (Pediatric, Adult), Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy), and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 2-3個工作天內

價格

2025年全球止咳糖漿市場規模達63億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到87億美元，2026年至2034年的複合年成長率為3.51%。市場成長的主要促進因素是上呼吸道感染疾病（URTI）和其他呼吸道疾病發生率的上升，以及止咳糖漿在一般零售商店和藥局的易得性。

全球止咳糖漿市場趨勢：

疾病數量不斷增加

感冒、流感、支氣管炎、百日咳、氣喘、慢性阻塞性肺病（COPD）和過敏症的盛行率不斷上升，推動了止咳糖漿的需求。例如，根據《經濟時報》2023年發表的報導報道，全球約有3.39億人患有氣喘。此外，菸草消費量的增加和不健康的生活方式也導致咳嗽病例增多，從而促進了市場成長。世界衛生組織（WHO）的數據顯示，每年有超過800萬人因吸菸而過早死亡，其中700萬人是直接吸菸者，170萬人是被動吸菸者。因此，各國政府和非政府組織正在發起多項計畫和宣傳活動來提高公眾意識提升。例如，澳洲肺臟基金會於2023年7月發起了一項慢性咳嗽意識宣傳活動，旨在提高大眾對成人和兒童慢性咳嗽的認知，並支持診斷。此外，老年人口的成長也進一步推動了止咳糖漿市場的發展。例如，根據世界衛生組織統計，2020年全球60歲及以上人口為10億，但預計2050年將達到21億人。

政府機構的法規環境

各國監管機構正在實施嚴格的法規，以確保主要止咳糖漿生產商遵守高標準的醫療規範。這提高了醫療專業人員對學名藥開發的認知，從而刺激了止咳糖漿市場的新機會。例如，印度藥品管理總局 (DCGI) 已致函所有邦和聯邦屬地，要求印度生產的止咳糖漿符合全球品質標準，並為此進行詳細的檢驗。據此，總局長要求與丙二醇 (PG) 生產商、止咳糖漿生產商和進口商開展聯合核查活動，以確保止咳糖漿生產中使用的或供應的原料符合國際檢驗。此外，世界衛生組織 (WHO) 也發布了另一種疑似受到污染的止咳糖漿的警告。世衛組織在 2022 年 7 月收到一份關於該止咳糖漿可能受到污染的報告後，對該批次止咳糖漿的樣本進行了檢測。此止咳糖漿由 Fourrts Laboratories 代表 Dabilife Pharma 在印度生產。這些嚴格的法規和檢查提高了產品質量，預計將在未來幾年內促進止咳糖漿市場的收入成長。

策略聯盟

主要廠商正積極開展併購活動，並不斷研發含有天然成分和草藥、具有增強免疫力功效的新產品，這反過來又推動了市場成長。例如，2023年，葛蘭素史克（GSK plc）與加拿大生技公司Bellus Health達成了一項價值20億美元的收購協議。該協議旨在加強GSK的臨床研發管線和全球市場地位。其產品組合包括糖漿和其他製劑，從而擴大了GSK在止咳糖漿市場的佔有率。同樣，2023年12月，美國食品藥物管理局（FDA）向默克公司提交了用於治療成人難治性慢性咳嗽（RCC）的新藥認證申請（NDA），並向FDA發出了完整回复函（CRL）。主要廠商正進一步推出含有天然成分的止咳糖漿，以擴大基本客群，這是止咳糖漿市場近期的趨勢。例如，Vitae Health Innovation公司推出了“VITATUSS”，這是一種含有接骨木果、百里香、藥蜀葵、錦葵和沙棘萃取物的天然糖漿。同時，Sun Pharmaceutical Industries Ltd.宣布推出“Chericof 12”，這是一種用於緩解咳嗽的止咳糖漿。據該公司稱，這是印度首款可提供長達12小時止咳效果的處方箋止咳糖漿。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球止咳糖漿市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品類型分類

  • 祛痰藥
  • 止咳藥/鎮咳藥
  • 複方製劑

第7章 市場區隔：依年齡層別分類

  • 兒童
  • 成人

第8章 市場區隔：依分銷通路分類

  • 零售藥房
  • 醫院藥房
  • 網路藥房

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Acella Pharmaceuticals LLC
    • Bayer AG
    • GlaxoSmithKline PLC
    • Johnson & Johnson
    • Pfizer Inc.
    • Prestige Consumer Healthcare Inc.
    • Reckitt Benckiser Group PLC
    • Sanofi
    • Sun Pharmaceutical Industries Limited
    • The Procter & Gamble Company
Product Code: SR112026A3917

The global cough syrup market size reached USD 6.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 8.7 Billion by 2034, exhibiting a growth rate (CAGR) of 3.51% during 2026-2034. The increasing occurrence of upper respiratory tract infections (URTIs) and other respiratory disorders, along with the easy availability of cough syrups in general stores and pharmacies, is primarily driving the market growth.

Global Cough Syrup Market Trends:

Growing Medical Conditions

The rising prevalence of cold, flu, bronchitis, pertussis, asthma, chronic pulmonary obstructive disease (COPD), and allergies is driving the need for cough syrups. For example, according to an article published by the Economic Times in 2023, around 339 million individuals are affected by asthma globally. Furthermore, the elevating cough cases, owing to the increasing tobacco consumption and unhealthy lifestyles, are also stimulating the market growth. Besides this, as per the World Health Organization (WHO), every year, more than 8 million people die prematurely from tobacco consumption. Among these, 7 million are direct smokers, and 1.7 million are second-hand smokers. Consequently, government and non-government organizations are launching numerous programs and campaigns to generate awareness among the population. For example, in July 2023, the Lung Foundation in Australia launched a chronic cough awareness campaign to raise awareness and support diagnosis in adults and pediatrics. In addition to this, the expanding geriatric population is further contributing to the cough syrup market outlook. For instance, according to the WHO, individuals aged 60 and above were 1 billion in 2020 and are expected to reach 2.1 billion by 2050.

Regulatory Environment by Government Bodies

Regulatory authorities across countries are implementing stringent rules to ensure leading companies of cough syrups comply with high medical standards. In line with this, they are generating awareness among healthcare professionals to develop generic drugs, thereby catalyzing the cough syrup market recent opportunities. For instance, in a letter written to all states and union territories, the Drugs Controller General of India (DCGI) asked to ensure that cough syrups produced in India are of global standard quality for which a detailed verification should be undertaken. In line with this, he asked for a joint verification drive on propylene glycol (PG) manufacturers, cough syrup manufacturers, and importers to ensure that the raw material utilized or supplied for the manufacturing of cough syrups is as per the global protocol. Additionally, the World Health Organization (WHO) has flagged another cough syrup for the presence of contaminants. The WHO tested a sample from a specific batch of the syrup after it received a report in July 2022 regarding possible contamination. Fourrts Laboratories produced the cough syrup on behalf of another company in India called Dabilife Pharma. These stringent regulations and checks will improve the quality of products, which is expected to propel the cough syrup market revenue in the coming years.

Strategic Alliances

Prominent key players are entering into mergers and acquisitions and are constantly working towards novel product developments that are usually formulated with natural ingredients and herbs with immunity-boosting effects. This, in turn, is driving the market forward. For example, in 2023, GSK plc. signed an acquisition deal with one of the Biotech firms in Canada, Bellus Health, for US$ 2 Billion. This deal was done to strengthen GSK's clinical pipeline portfolio and market position across the globe. The portfolio also included syrups and other formulations, thereby elevating the cough syrup market share. Similarly, in December 2023, the U.S. FDA issued a complete response letter (CRL) about Merck's new drug application (NDA) for gefapixant, one of the drugs to treat refractory chronic cough (RCC) in adults. Key players are further introducing cough syrups with natural ingredients to expand their consumer base, which is cough syrup market recent developments. For instance, Vitae Health Innovation launched VITATUSS, a natural syrup formulated with elderberry, thyme, althaea, mallow, and sea buckthorn extract. In line with this, Sun Pharmaceutical Industries Ltd. announced the introduction of a formulation in cough management called Chericof 12. The company said this was the first prescription cough syrup across India that offer relief for up to 12 hours.

Global Cough Syrup Market Segmentation:

The publisher provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2026-2034. Our report has categorized the market based on the product type, age group and distribution channel.

Breakup by Product Type:

  • Expectorants
  • Cough Suppressants/Antitussives
  • Combination Medications

Currently, cough suppressants/antitussives account for the majority of the global market share

Symptoms related to cold and cough are usually managed by utilizing over the counter (OTC) medicines. Cough suppressants, or antitussive drugs, are medicines that are adopted to control and relieve a cough. While many antitussives are widely accessible OTC, a few antitussives are only available with a prescription. Antitussives are used in various types of formulations, such as capsules, liquids, tablets, and syrups. For example, Dextromethorphan, one of the most widely utilized cough suppressants in the U.S., was compared with codeine, the traditional antitussive in Europe, in a double-blind, crossover trial using both subjective and objective assessment of efficacy in sixteen patients with chronic cough. Dextromethorphan lowered cough intensity more than codeine and was considered the better antitussive by most patients. This, in turn, represents key factors propelling the cough syrup market growth in the segmentation.

Breakup by Age Group:

  • Pediatric
  • Adult

Adult currently holds the largest market share

Adults commonly suffer from chronic and acute cough, owing to unhealthy lifestyles and high exposure to tobacco. For example, as per the study published by the European Respiratory Society in 2020, approximately 10% of the adult population suffers from chronic cough, on account of the impaired quality of life. Consequently, the expanding adult population is escalating the cough syrup market demand, thereby stimulating the adoption of cough remedies.

Breakup by Distribution Channel:

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy

Currently, retail pharmacy exhibits a clear dominance in the market

As per the cough syrup market overview, the easy product availability via distribution channels, such as retail pharmacy, owing to its accessibility and convenience, is bolstering the segmentation growth. For example, according to the Federal Union of German Associations of Pharmacists (ABDA), around 18,068 community pharmacies across Germany cater to medical needs in 2023. In addition to this, the rising number of generic and branded remedy products in retail pharmacy chains, including Walmart Stores Inc. and Walgreens, is further acting as another significant growth-inducing factor. Moreover, the increasing tie-ups of hospitals with these chains are strengthening the cough syrup market recent price.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

According to the cough syrup market statistics, Asia Pacific exhibits a clear dominance in the market

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia Pacific accounted for the largest market share.

The regional market is primarily driven by the numerous partnerships among pharmaceutical companies and government organizations, generally to develop novel generic drugs and generate awareness among individuals and healthcare professionals. Moreover, key players are emphasizing on innovative packaging solutions, which is contributing to the growth of the market. Apart from this, the inflating expenditure capacities of individuals across the region and the elevating focus on preventive healthcare are further validating the cough syrup market forecast. According to a report by the FMCG Gurus, more than 55% of people in the Asia Pacific region have been more conscious about boosting their immunity since the sudden outbreak of the COVID-19 pandemic.

Competitive Landscape:

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Acella Pharmaceuticals LLC
  • Bayer AG
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Pfizer Inc.
  • Prestige Consumer Healthcare Inc.
  • Reckitt Benckiser Group PLC
  • Sanofi
  • Sun Pharmaceutical Industries Limited
  • The Procter & Gamble Company

Key Questions Answered in This Report

  • 1.What was the size of the global cough syrup market in 2025?
  • 2.What is the expected growth rate of the global cough syrup market during 2026-2034?
  • 3.What has been the impact of COVID-19 on the global cough syrup market?
  • 4.What are the key factors driving the global cough syrup market?
  • 5.What is the breakup of the global cough syrup market based on the product type?
  • 6.What is the breakup of the global cough syrup market based on the age group?
  • 7.What is the breakup of the global cough syrup market based on the distribution channel?
  • 8.What are the key regions in the global cough syrup market?
  • 9.Who are the key players/companies in the global cough syrup market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cough Syrup Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Expectorants
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Cough Suppressants/Antitussives
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Combination Medications
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Age Group

  • 7.1 Pediatric
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Adult
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Retail Pharmacy
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hospital Pharmacy
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacy
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Acella Pharmaceuticals LLC
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Bayer AG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 GlaxoSmithKline PLC
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Johnson & Johnson
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Pfizer Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Prestige Consumer Healthcare Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Reckitt Benckiser Group PLC
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Sanofi
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Sun Pharmaceutical Industries Limited
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 The Procter & Gamble Company
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Cough Syrup Market: Major Drivers and Challenges
  • Figure 2: Global: Cough Syrup Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Cough Syrup Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Cough Syrup Market: Breakup by Product Type (in %), 2025
  • Figure 5: Global: Cough Syrup Market: Breakup by Age Group (in %), 2025
  • Figure 6: Global: Cough Syrup Market: Breakup by Distribution Channel (in %), 2025
  • Figure 7: Global: Cough Syrup Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Cough Syrup (Expectorants) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Cough Syrup (Expectorants) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Cough Syrup (Cough Suppressants/Antitussives) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Cough Syrup (Cough Suppressants/Antitussives) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Cough Syrup (Combination Medications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Cough Syrup (Combination Medications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Cough Syrup (Pediatric) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Cough Syrup (Pediatric) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Cough Syrup (Adult) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Cough Syrup (Adult) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Cough Syrup (Retail Pharmacy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Cough Syrup (Retail Pharmacy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Cough Syrup (Hospital Pharmacy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Cough Syrup (Hospital Pharmacy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Cough Syrup (Online Pharmacy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Cough Syrup (Online Pharmacy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: North America: Cough Syrup Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: North America: Cough Syrup Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: United States: Cough Syrup Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: United States: Cough Syrup Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Canada: Cough Syrup Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Canada: Cough Syrup Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Asia-Pacific: Cough Syrup Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Asia-Pacific: Cough Syrup Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: China: Cough Syrup Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: China: Cough Syrup Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Japan: Cough Syrup Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Japan: Cough Syrup Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: India: Cough Syrup Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: India: Cough Syrup Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: South Korea: Cough Syrup Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: South Korea: Cough Syrup Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Australia: Cough Syrup Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Australia: Cough Syrup Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Indonesia: Cough Syrup Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Indonesia: Cough Syrup Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Others: Cough Syrup Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Others: Cough Syrup Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Europe: Cough Syrup Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Europe: Cough Syrup Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Germany: Cough Syrup Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Germany: Cough Syrup Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: France: Cough Syrup Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: France: Cough Syrup Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: United Kingdom: Cough Syrup Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: United Kingdom: Cough Syrup Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Italy: Cough Syrup Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Italy: Cough Syrup Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Spain: Cough Syrup Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Spain: Cough Syrup Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Russia: Cough Syrup Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Russia: Cough Syrup Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Others: Cough Syrup Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Others: Cough Syrup Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Latin America: Cough Syrup Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Latin America: Cough Syrup Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Brazil: Cough Syrup Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Brazil: Cough Syrup Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Mexico: Cough Syrup Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Mexico: Cough Syrup Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Others: Cough Syrup Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Others: Cough Syrup Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Middle East and Africa: Cough Syrup Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Middle East and Africa: Cough Syrup Market: Breakup by Country (in %), 2025
  • Figure 72: Middle East and Africa: Cough Syrup Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Global: Cough Syrup Industry: SWOT Analysis
  • Figure 74: Global: Cough Syrup Industry: Value Chain Analysis
  • Figure 75: Global: Cough Syrup Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cough Syrup Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Cough Syrup Market Forecast: Breakup by Product Type (in Million USD), 2026-2034
  • Table 3: Global: Cough Syrup Market Forecast: Breakup by Age Group (in Million USD), 2026-2034
  • Table 4: Global: Cough Syrup Market Forecast: Breakup by Distribution Channel (in Million USD), 2026-2034
  • Table 5: Global: Cough Syrup Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Cough Syrup Market: Competitive Structure
  • Table 7: Global: Cough Syrup Market: Key Players